 |
PDBsum entry 6bcf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/DNA
|
PDB id
|
|
|
|
6bcf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Active site residue identity regulates cleavage preference of laglidadg homing endonucleases.
|
 |
|
Authors
|
 |
T.A.Mcmurrough,
C.M.Brown,
K.Zhang,
G.Hausner,
M.S.Junop,
G.B.Gloor,
D.R.Edgell.
|
 |
|
Ref.
|
 |
Nucleic Acids Res, 2018,
46,
11990-12007.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
LAGLIDADG homing endonucleases (meganucleases) are site-specific mobile
endonucleases that can be adapted for genome-editing applications. However, one
problem when reprogramming meganucleases on non-native substrates is indirect
readout of DNA shape and flexibility at the central 4 bases where cleavage
occurs. To understand how the meganuclease active site regulates DNA cleavage,
we used functional selections and deep sequencing to profile the fitness
landscape of 1600 I-LtrI and I-OnuI active site variants individually challenged
with 67 substrates with central 4 base substitutions. The wild-type active site
was not optimal for cleavage on many substrates, including the native I-LtrI and
I-OnuI targets. Novel combinations of active site residues not observed in known
meganucleases supported activity on substrates poorly cleaved by the wild-type
enzymes. Strikingly, combinations of E or D substitutions in the two
metal-binding residues greatly influenced cleavage activity, and E184D variants
had a broadened cleavage profile. Analyses of I-LtrI E184D and the wild-type
proteins co-crystallized with the non-cognate AACC central 4 sequence revealed
structural differences that correlated with kinetic constants for cleavage of
individual DNA strands. Optimizing meganuclease active sites to enhance cleavage
of non-native central 4 target sites is a straightforward addition to
engineering workflows that will expand genome-editing applications.
|
 |
|
|
|
|
 |